Formulate
Jobs
Companies
Products
Indications
Toggle theme
Toggle theme
Menu
Home
Products
SOTALOL HYDROCHLORIDE
SOTALOL HYDROCHLORIDE
Peak
sotalol hydrochloride
AltaThera Pharmaceuticals
NDA
INTRAVENOUS
SOLUTION
Approved
Jul 2009
Lifecycle
Peak
Competitive Pressure
0
/100
Overview
Patent & IP
6
Loss of Exclusivity
LOE Date
Aug 21, 2039
163 months away
Patent Expiry
Aug 21, 2039
Patent Records (5)
Patent #
Expiry
Type
Use Code
12403109
Aug 14, 2028
U-2769
10512620
Aug 14, 2038
U-3547
11696902
Aug 14, 2038
U-2769
12390431
Aug 14, 2038
U-2769
10799138
Apr 5, 2039
U-3125
Company
AltaThera Pharmaceuticals
IL - Chicago
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers